The pharmaceutical firm Merck announced last week that an antiviral pill it’s developing can cut hospitalizations and deaths among people with COVID-19 by half. The results haven’t yet been peer reviewed. But if the drug candidate, molnupiravir, is authorized by … Continue reading How Antiviral Pill Molnupiravir Shot Ahead in the COVID Drug Hunt